Savvy Updates 2/12/24: Insulet Wins CE Mark for O5 & Abbott Libre, Sinocare iCAN i3 CGM, Sync CGMs w/SmartWatch, Salmon’s New Compounds for Heart Health, D & Aging & Muscle Loss, “How Low is Too Low” Video with TCOYD, A Few More Books Left, Benefits/Risks of Pumps & Closed-Loop Systems, Valentine’s Day Carb List
Insulet wins CE mark for integration of insulin pump with Abbott CGM by Nick Paul Taylor for MedTechDive.com, 8 February 2024. Since the launch of the Omnipod 5 in 2022, Insulet has worked to integrate the pump with devices from Abbott, Dexcom’s main competitor for...
Savvy Updates 1/29/24: Modular Medical Submits to FDA, Insulin Nano Carriers, Know Labs at ATTD, Samsung & Non-Invasive CGM, PBMs HUGE Spending Increase, (video) Microbiome & T1D, T1D & Arthritis, Insulin Pumps & Pregnancy
Modular Medical submits next-gen insulin pump for FDA clearance by Sean Whooley for DrugDeliveryBusiness.com, 19 January 2024. Modular Medical announced it submitted its next-generation MODD1 insulin pump to the FDA for 510(k) clearance. San Diego-based Modular...
Savvy Updates 1/22/24: embecta Patch Pump Submits to FDA, Apple Redesigns Smart Watch, SiBionics GCM Not Accurate Enough, Dr. Jeremy Pettus/Microdosing w/Glucagon, SERIOUS DKA Advice, CMS Changes Rules on Prior Authorization, Fruit Bats & New T1D Treatments
embecta Announces FDA 510(k) Submission for Insulin Patch Pump announced by Embecta, 9 January 2024. Embecta Corp., a global diabetes care company with a 100-year legacy in insulin delivery, announced that it has submitted a 510(k) premarket filing to the U.S. Food...
Savvy Updates 1/15/24: t:slim X2 Integrates with Libre 2, Vertex Pauses VX-880 Trial, Dexcom to Launch CGM for T2Ds, Loneliness of T1D carers, NEW US-based TRIAL: Diamyd
Tandem integrates t:slim X2 insulin pump with Abbott’s FreeStyle sensor on GlobalData.com, 9 January 2024. Abbott has announced that Tandem Diabetes Care’s t:slim X2 insulin pump has become the first automated insulin delivery (AID) system to integrate with its...
Savvy Updates 1/8/24: PharmSens Submits for Patch Pump, FDA OKs Florida to Import Drugs from Canada, Battery-Independent Fluorescent Nanosensor in Development, Heat & Hypo Risk in Older T1Ds, GlucoTrack Implantable BG Monitor Trials, Apple Watches Back on Sale
PharmaSens submits insulin patch pump for FDA approval PharmaSens announced that it applied for FDA approval for its Niia Essential insulin patch pump system. FDA submission follows the pump’s recent ISO 13485 certification for the Switzerland-based company. This...
More Diabetes Blogs